Human Papillomavirus (HPV), High Risk by Transcription-Mediated Amplification (TMA), ThinPrep
2007893
Ordering Recommendation
Adjunct to cytology (Pap smear) for cervical cancer screening and monitoring.
Mnemonic
HPV TMA
Methodology
Qualitative Transcription-Mediated Amplification
Performed
Tue, Thu, Sat
Reported
1-5 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
 
Specimen Required
Patient Preparation
Females should avoid high concentrations of antifungal cream or contraceptive jelly, and should not douche prior to time of collection.  
Collect
Cervical, anal or vaginal specimens with the ThinPrep Pap Test Collection kit.  
Specimen Preparation
Vortex ThinPrep PreservCyt solution and transfer 1 mL to an APTIMA Specimen Transfer Tube (ARUP supply #42711) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787.  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Specimens in any media other than indicated above.  
Remarks
Specimen source required.  
Stability
ThinPrep PreservCyt solution: Ambient: 1 month; Refrigerated: 1 month; Frozen: 2 years
APTIMA Specimen Transfer Tube: Ambient: 2 months; Refrigerated: 2 months; Frozen: 2 years  
Reference Interval
Negative  
Interpretive Data
This test detects E6/E7 viral messenger RNA of the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 associated with cervical cancer and its precursor lesions. Cross-reactivity with low-risk HPV genotypes 26, 67, 70, and 82 may occur. Sensitivity may be affected by specimen collection methods, stage of infection, and the presence of interfering substances. Results should be interpreted in conjunction with other available laboratory and clinical data.

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes. HPV testing should not be used for screening or management of atypical squamous cells of undetermined significance (ASCUS) in women under age 21.  
Note
 
CPT Code(s)
87621
Components
Component Test Code*Component Chart Name
0060752HPV Source
2007891HPV, High Risk by TMA
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • HPV HR E6/E7 TMA
  • HPV RNA
  • Nucleic Acid Amplification Test (NAAT)